The global divide between rich and poor nations is making it harder to get agreement on sharing tissue samples for research and for the development of drugs and vaccines for a variety of infectious diseases.

Of course, right now, the top priority is the pandemic influenza.

The only way to get medications and vaccinations we need is with incentives for pharmaceutical companies, says Margaret Chan, director-general of WHO (World Health Organization).

Incentives must be provided with patents, which protect any drug from generic competition for a specific time period.

The poor nations say that they cannot afford patented medicines, which cost more than generics.

The director-general is quoted in the full story that the pricing system can be adjusted to deal with that problem.

The poor nations are not persuaded, according to their leaders, who are objecting to this proposal.

In the meantime, the pandemic (H1N1) flu continues its travels.

Reuters

“Pharmaceutical firms need incentives, including lucrative patents, to keep creating drugs and vaccines against emergent threats such as the H1N1 influenza pandemic, the World Health Organisation’s head said on Tuesday.

“Progress in public health depends on innovation. Some of the greatest strides forward for health have followed the development and introduction of new medicines and vaccines,” said WHO Director-General Margaret Chan said.

“Chan, who last month declared a full pandemic underway from the H1N1 virus, said that patents can help ensure that companies develop medicines to “stay ahead of the development of drug resistance” in diseases like malaria and tuberculosis.

“The discovery of isolated H1N1 infections that resist the anti-viral Tamiflu, made by Roche (ROG.VX) and Gilead (GILD.O), and the global scramble to secure flu vaccines have shown the importance of robust research and development, Chan said.

“Innovation is needed to keep pace with the emergence of new diseases, including pandemic influenza caused by the new H1N1 virus,” she told a meeting on intellectual property and health, a contentious issue that has divided rich and poor nations.”

Source: Reuters, July 14, 2009